Legend Biotech (LEGN) Cost of Revenue (2019 - 2025)

Legend Biotech has reported Cost of Revenue for 7 years, with the latest figure at $64.2 million in Q4 2025.

• For the quarter ending Q4 2025, Cost of Revenue rose 31.29% year-over-year to $64.2 million; the trailing twelve-month figure through Dec 2025 stood at $205.8 million (up 39.59% YoY), and the FY2025 full-year result was $205.8 million, up 39.53% from the prior year.
• Cost of Revenue for Q4 2025 stood at $64.2 million, up from $52.6 million in the prior quarter.
• The five-year high for Cost of Revenue was $13.4 billion in Q1 2021, with the low at $33677.0 in Q4 2023.
• Historically, Cost of Revenue has averaged $700.7 million across 5 years, with a median of $26.6 million in 2022.
• Annual changes were most pronounced in 2021 — Cost of Revenue surged 204896.18% — and 2023, when it slumped 99.87%.
• Legend Biotech's Cost of Revenue stood at $52.8 million in 2021, then tumbled by 51.1% to $25.8 million in 2022, then tumbled by 99.87% to $33677.0 in 2023, then jumped by 145102.96% to $48.9 million in 2024, then soared by 31.29% to $64.2 million in 2025.
• The last three Cost of Revenue figures came in at $64.2 million (Q4 2025), $52.6 million (Q3 2025), and $48.1 million (Q2 2025), per Business Quant data.